Zhejiang Syncozymes Bio-pharmaceutical Co., Ltd. was established at the end of 2017 and is headquartered in Binhai New District, Shaoxing, Zhejiang. The company's biological enzyme series products and chemical drug industrialization base project is a major industrial project in Zhejiang Province, covering an area of 230 acres. The construction will start in May 2020 and is expected to be put into operation by the end of 2021. After being put into production, it will achieve an annual output of 200 tons of biological enzyme series products, 100 tons of coenzyme NMN/NAD/NADH/NADP series products and chemical drug preparation products.
The company has three wholly-owned subsidiaries: SyncoZymes (Shanghai) Co., Ltd., Zhejiang Supor Pharmaceutical Co., Ltd. and Hangzhou JiuShi Trading Co., Ltd.
SyncoZymes (Shanghai) Co., Ltd. was established at the end of 2007 and is located in the Southern District of Zhangjiang Hi-Tech Park, Pudong, Shanghai—in the International Medical Park. The main business includes: the development and application of biological enzymes; the development and production of pharmaceutical intermediates, bulk drugs and functional chemicals. The company's main products are coenzyme NAD products, (including NMN, NAD, NADP, NADH, NADPH) biological enzymes, pharmaceutical raw materials and intermediates. SyncoZymes (Shanghai) Co., Ltd. has an experienced management team and a first-class R&D team, including many outstanding experts in the fields of bioenzyme development, drug synthesis process development, drug quality research, etc., in medicinal chemistry, green chemistry, synthetic process development, Many important fields such as API development, fermentation and protein purification, and bioengineering are well-known and competitive. SyncoZymes (Shanghai) Co., Ltd. has a strong biotechnology platform, chemical technology platform, testing platform and GMP production system, focusing on the development and application of biological enzymes, focusing on the application of green biotechnology in pharmaceutical intermediates, bulk drugs, and fine chemicals. The R&D and production of chemicals and health products, while providing high-end CRO, CMO services, testing and quality research services for companies in the biomedical industry.
The company is committed to the most cutting-edge research and development in the field of green pharmaceuticals, leading the development of the chemical pharmaceutical industry with green biotechnology, and providing novel products and high-quality services for the pharmaceutical industry. It is a high-tech enterprise in Shanghai and also a Shanghai city“ Specialized, refined, special, new & rdquo; enterprise.
SyncoZymes (Shanghai) Co., Ltd. has customers and partners all over the world, and has formed close cooperative relations with many pharmaceutical companies in North America, Europe, India and China. SyncoZymes (Shanghai) Co., Ltd. has always adhered to the principle of enhancing customer value through technological innovation and quality service, better serving our customers, and becoming an ideal partner for customers.
Zhejiang Supor Pharmaceutical Co., Ltd. is an API manufacturer that strictly complies with GMP requirements and high standards. Founded in 2002, the company is located in the core city of Zhejiang Dawan District—Shaoxing, close to the Shanghai-Hangzhou-Ningbo Expressway and Hangzhou Bay, with a superior geographical location. Supor Pharmaceuticals is committed to the research and development of new drug technologies, especially with technical advantages in the development and production of anti-anaerobic drugs, anti-hypertensive drugs, antidepressants, and peptide drugs. At present, it has formed unique products from research, production to sales. chain. There are specialized production workshops, strict quality management and testing systems, and complete EHS management systems.
The quality system of Supor Pharmaceutical Company has passed national GMP certification, Australian TGA certification, US FDA certification, and EU EDQM certification. Except for some products sold in the domestic market, the products are mainly sold in the international market. The company has established a complete EHS system and passed ISO14000 and 18000 system certification. The company attaches great importance to technological research and development, and is a national "high-tech enterprise". The company's R&D center has been identified as "Zhejiang High-tech Drug R&D Center".
Supor Pharmaceuticals is committed to continuous innovation, continuous improvement, high-standard quality management system, continuous improvement of the management team's drug production and operation management professionalism, and gradually enters the ranks of high-level API manufacturers. In the future, the company will use peptide drugs as products Positioning and focus of enterprise development, further transforming into high-end API and high-end preparation pharmaceutical companies, and strive to become the world's leading supplier of peptide drugs; and actively promote green pharmaceutical technology to become the leading domestic green chemical technology-based Modern pharmaceutical companies.
Hangzhou Jiushi Trading Co., Ltd., established in 2019, is mainly engaged in marketing planning and marketing services.